IL31146A0 - 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them - Google Patents

1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL31146A0
IL31146A0 IL31146A IL3114668A IL31146A0 IL 31146 A0 IL31146 A0 IL 31146A0 IL 31146 A IL31146 A IL 31146A IL 3114668 A IL3114668 A IL 3114668A IL 31146 A0 IL31146 A0 IL 31146A0
Authority
IL
Israel
Prior art keywords
benzodiazepin
diones
tetrahydro
preparation
pharmaceutical compositions
Prior art date
Application number
IL31146A
Other versions
IL31146A (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL31146A0 publication Critical patent/IL31146A0/en
Publication of IL31146A publication Critical patent/IL31146A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
IL31146A 1967-11-24 1968-11-24 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them IL31146A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (en) 1967-11-24 1967-11-24 Process for the preparation of new 1-phenyl-4-alkyl-3H-1,4-benzodiazepine-2,5- [1H, 4H] -diones

Publications (2)

Publication Number Publication Date
IL31146A0 true IL31146A0 (en) 1969-01-29
IL31146A IL31146A (en) 1972-04-27

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
IL31146A IL31146A (en) 1967-11-24 1968-11-24 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
AT (1) AT280290B (en)
BE (1) BE724364A (en)
BR (1) BR6804236D0 (en)
CH (1) CH523265A (en)
DE (1) DE1810423B2 (en)
DK (1) DK124950B (en)
ES (2) ES360410A1 (en)
FR (2) FR1593335A (en)
GB (1) GB1173540A (en)
IE (1) IE32504B1 (en)
IL (1) IL31146A (en)
NL (1) NL6815755A (en)
SE (1) SE356979B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (en) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim New substituted 1,3-dihydro-2H-1 ^ -benzodiazepine ^ -ones
BE793460A (en) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim NEWS 1-ARYL-3H, 1,4-BENZODIAZEPINE-2,5- (1H
EP2062583B1 (en) * 1999-04-30 2012-12-26 The Regents of the University of Michigan Therapeutic applications of pro-apoptotic benzodiazepines
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7144880B2 (en) 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
EP1845996A4 (en) 2005-01-03 2009-04-29 Univ Michigan Compositions and methods relating to novel compounds and targets thereof
WO2007053193A2 (en) 2005-06-01 2007-05-10 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
CA2628193C (en) 2005-11-01 2012-08-14 The Regents Of The University Of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
MX2008015488A (en) 2006-06-09 2009-02-12 Univ Michigan Compositions and methods relating to novel compounds and targets thereof.
MX2009009645A (en) 2007-03-09 2009-11-19 Univ Michigan Compositions and methods relating to novel compounds and targets thereof.
JP2010526825A (en) 2007-05-10 2010-08-05 エーエムアール テクノロジー インコーポレイテッド Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and their use to block reuptake of norepinephrine, dopamine and serotonin
CA2698248C (en) 2007-09-14 2017-08-29 The Regents Of The University Of Michigan Phenyl acyl guanidine derivatives as f1f0-atpase inhibitors and the use thereof
AU2008323945B2 (en) 2007-11-06 2013-11-28 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
AU2009291632B2 (en) 2008-09-11 2013-04-04 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
WO2011035124A1 (en) 2009-09-18 2011-03-24 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
CA2780333C (en) 2009-11-17 2016-05-24 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
WO2011062766A2 (en) 2009-11-17 2011-05-26 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CA2923835C (en) * 2013-09-11 2022-11-29 The Administrators Of The Tulane Educational Fund Novel anthranilic amides and the use thereof

Also Published As

Publication number Publication date
ES360410A1 (en) 1970-11-01
IE32504B1 (en) 1973-08-22
FR1593335A (en) 1970-05-25
CH523265A (en) 1972-05-31
GB1173540A (en) 1969-12-10
BE724364A (en) 1969-05-22
NL6815755A (en) 1969-05-28
SE356979B (en) 1973-06-12
ES378977A1 (en) 1973-01-16
DE1810423B2 (en) 1973-03-22
BR6804236D0 (en) 1973-02-08
AT280290B (en) 1970-04-10
IL31146A (en) 1972-04-27
DE1810423C3 (en) 1973-10-11
IE32504L (en) 1969-05-24
FR8310M (en) 1970-11-23
DK124950B (en) 1972-12-11
DE1810423A1 (en) 1969-10-09

Similar Documents

Publication Publication Date Title
IL31146A0 (en) 1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-diones,their preparation and pharmaceutical compositions containing them
IL33348A (en) Quinazolines,their preparation and pharmaceutical compositions containing them
IL30326A0 (en) 1,2,4-triazine-5-ones and their preparation
IL31246A0 (en) Phenylethanolamines,their preparation and pharmaceutical and veterinary compositions containing them
IL30282A (en) 1,4-benzodiazepines and benzodiazepin-2-ones,their preparation and pharmaceutical compositions containing them
IL27934A (en) 1-pyrryl-2-aminoethanols,their preparation and pharmaceutical compositions containing them
IL30001A0 (en) Phenoxyalkanolamines,processes for their preparation and pharmaceutical compositions containing them
IL32444A0 (en) 2-arylaminoimidazolines,their preparation and pharmaceutical compositions containing them
IL32481A0 (en) Diphenylmethoxyethylamine derivatives,their preparation and pharmaceutical compositions containing them
IL30369A0 (en) Aralkylthioamino acids,their preparation and pharmaceutical compositions containing them
IL32801A (en) Hexahydroazepines,their preparation and pharmaceutical compositions containing them
IL35689A (en) 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL33103A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL33624A0 (en) 1-pyridyl-2-imidazolones,their preparation and pharmaceutical compositions containing them
IL32699A0 (en) 6-substituted-13-polycarbonalkyl-18,19-dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL31494A0 (en) New 1,3,5-triazines,their preparation,and therapeutic compositions containing them
IL33119A (en) 4,5-epoxy-1,3,4,5-tetrahydro-5-phenyl-2h-1,4-benzodiazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them
IL32705A0 (en) Acylphenyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL32088A0 (en) Benzodiazepindiones,their preparation and pharmaceutical compositions containing them
IL30132A0 (en) 2-amino-3-carbonamido-quinoxaline di-n-oxides,their preparation and pharmaceutical compositions containing them
IL31987A0 (en) Benzodiazocines,their preparation and pharmaceutical composition containing them
IL31452A0 (en) 1-amino-3-hydroxy-guanidine derivatives,their preparation and pharmaceutical compositions containing them
IL32087A0 (en) New 1,2-oxazine derivatives,their preparation and pharmaceutical compositions containing them
IL31676A0 (en) 5,5-dimethylhydantoine chloralhydrate,its preparation and pharmaceutical compositions containing it
IL32520A0 (en) N-cinnamyl-n'-benzhydryl piperazines,their preparation and pharmaceutical compositions containing them